BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19273283)

  • 41. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.
    Filippova GN; Fagerlie S; Klenova EM; Myers C; Dehner Y; Goodwin G; Neiman PE; Collins SJ; Lobanenkov VV
    Mol Cell Biol; 1996 Jun; 16(6):2802-13. PubMed ID: 8649389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
    Li J; Piao YF; Jiang Z; Chen L; Sun HB
    World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.
    Kobayashi S; Hoshino T; Hiwasa T; Satoh M; Rahmutulla B; Tsuchida S; Komukai Y; Tanaka T; Matsubara H; Shimada H; Nomura F; Matsushita K
    Oncotarget; 2016 Dec; 7(50):82493-82503. PubMed ID: 27756887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hfp inhibits Drosophila myc transcription and cell growth in a TFIIH/Hay-dependent manner.
    Mitchell NC; Johanson TM; Cranna NJ; Er AL; Richardson HE; Hannan RD; Quinn LM
    Development; 2010 Sep; 137(17):2875-84. PubMed ID: 20667914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repression of cyclin D1: a novel function of MYC.
    Philipp A; Schneider A; Väsrik I; Finke K; Xiong Y; Beach D; Alitalo K; Eilers M
    Mol Cell Biol; 1994 Jun; 14(6):4032-43. PubMed ID: 8196642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF.
    Lee TC; Ziff EB
    J Biol Chem; 1999 Jan; 274(2):595-606. PubMed ID: 9872993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
    Tonelli R; McIntyre A; Camerin C; Walters ZS; Di Leo K; Selfe J; Purgato S; Missiaglia E; Tortori A; Renshaw J; Astolfi A; Taylor KR; Serravalle S; Bishop R; Nanni C; Valentijn LJ; Faccini A; Leuschner I; Formica S; Reis-Filho JS; Ambrosini V; Thway K; Franzoni M; Summersgill B; Marchelli R; Hrelia P; Cantelli-Forti G; Fanti S; Corradini R; Pession A; Shipley J
    Clin Cancer Res; 2012 Feb; 18(3):796-807. PubMed ID: 22065083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress.
    Liu J; Chung HJ; Vogt M; Jin Y; Malide D; He L; Dundr M; Levens D
    EMBO J; 2011 Mar; 30(5):846-58. PubMed ID: 21285945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
    Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
    Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silencing of human c-myc oncogene expression by poly-DNP-RNA.
    Shen L; Zhang C; Ambrus JL; Wang JH
    Oligonucleotides; 2005; 15(1):23-35. PubMed ID: 15788898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
    Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
    Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.
    He L; Liu J; Collins I; Sanford S; O'Connell B; Benham CJ; Levens D
    EMBO J; 2000 Mar; 19(5):1034-44. PubMed ID: 10698944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.
    Weeda G; Rossignol M; Fraser RA; Winkler GS; Vermeulen W; van 't Veer LJ; Ma L; Hoeijmakers JH; Egly JM
    Nucleic Acids Res; 1997 Jun; 25(12):2274-83. PubMed ID: 9173976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-myc expression: keep the noise down!
    Chung HJ; Levens D
    Mol Cells; 2005 Oct; 20(2):157-66. PubMed ID: 16267388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.
    Hossain A; Li C; Saunders GF
    Mol Endocrinol; 2004 Jun; 18(6):1428-37. PubMed ID: 15044589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
    Arsura M; Deshpande A; Hann SR; Sonenshein GE
    Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The C-terminus of nucleolin promotes the formation of the c-MYC G-quadruplex and inhibits c-MYC promoter activity.
    González V; Hurley LH
    Biochemistry; 2010 Nov; 49(45):9706-14. PubMed ID: 20932061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression.
    McConnell MJ; Chevallier N; Berkofsky-Fessler W; Giltnane JM; Malani RB; Staudt LM; Licht JD
    Mol Cell Biol; 2003 Dec; 23(24):9375-88. PubMed ID: 14645547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.